Ayer Capital Management as of March 31, 2012
Portfolio Holdings for Ayer Capital Management
Ayer Capital Management holds 34 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 9.4 | $19M | 414k | 45.06 | |
| McKesson Corporation (MCK) | 9.1 | $18M | 204k | 87.77 | |
| Grifols S A | 6.5 | $13M | 1.7M | 7.71 | |
| Intermune cv 5.0% | 6.0 | $12M | 11M | 1.12 | |
| CIGNA Corporation | 5.6 | $11M | 225k | 49.25 | |
| Dynavax Technologies Corporation | 5.4 | $11M | 2.1M | 5.06 | |
| Cardinal Health (CAH) | 5.1 | $10M | 235k | 43.11 | |
| Oncothyreon | 5.0 | $9.9M | 2.3M | 4.36 | |
| Halozyme Therapeutics (HALO) | 5.0 | $9.8M | 771k | 12.76 | |
| Ariad Pharmaceuticals | 4.9 | $9.7M | 609k | 15.95 | |
| Novartis (NVS) | 4.4 | $8.7M | 156k | 55.41 | |
| Dendreon Corp cnv | 4.3 | $8.5M | 6.2M | 1.37 | |
| Sanofi-Aventis SA (SNY) | 2.9 | $5.7M | 148k | 38.75 | |
| NPS Pharmaceuticals | 2.7 | $5.3M | 778k | 6.84 | |
| D Horizon Pharma | 2.6 | $5.1M | 1.4M | 3.73 | |
| Chemocentryx | 1.9 | $3.8M | 355k | 10.66 | |
| Synta Pharmaceuticals | 1.9 | $3.7M | 852k | 4.35 | |
| Celldex Therapeutics | 1.6 | $3.1M | 614k | 5.09 | |
| Biolinerx Ltd-spons | 1.5 | $3.0M | 1.1M | 2.86 | |
| Array BioPharma | 1.5 | $2.9M | 865k | 3.40 | |
| BioSpecifics Technologies | 1.4 | $2.8M | 175k | 15.82 | |
| Threshold Pharmaceuticals | 1.4 | $2.7M | 312k | 8.80 | |
| Trius Therapeutics | 1.4 | $2.7M | 509k | 5.35 | |
| SciClone Pharmaceuticals | 1.1 | $2.1M | 338k | 6.31 | |
| Biomira Inc Cmn Stock cmn | 1.1 | $2.1M | 489k | 4.36 | |
| Uroplasty | 1.1 | $2.1M | 688k | 3.01 | |
| GTx | 1.0 | $1.9M | 500k | 3.85 | |
| Cyclacel Pharmaceuticals | 0.9 | $1.8M | 2.6M | 0.70 | |
| Sucampo Pharmaceuticals | 0.8 | $1.5M | 204k | 7.45 | |
| Verastem | 0.7 | $1.4M | 128k | 10.93 | |
| Alexza Pharmaceuticals | 0.6 | $1.2M | 2.0M | 0.62 | |
| Celgene Corporation | 0.6 | $1.2M | 602k | 1.95 | |
| UnitedHealth (UNH) | 0.5 | $1.1M | 18k | 58.93 | |
| Inovio Pharmaceuticals | 0.4 | $788k | 1.2M | 0.66 |
